Identifying new therapeutics for endometriosis using high throughput molecular and compound phenotypic screens
An increasingly popular approach to in vitro drug discovery is high-throughput screening (HTS). In addition to the therapeutic applications of drug discovery, HTS screens can also expand our knowledge about the molecular characteristics of cell function.
We are using HTS technology to identify drugs that could be suitable to investigate for therapeutic use in endometriosis, and which further our knowledge and understanding of the cellular pathways involved in endometriosis.
Prof Peter Rogers –Research Director at the Women’s
Dr Sarah Holdsworth-Carson - Research Fellow
Dr Jacqueline Donoghue - Research Fellow
Dr Megan Cock – Project Officer
Leonie Cann – Research Assistant
Molly Churchill – Research Assistant
This research has been funded by the Medical Research Future Fund (MRFF).
This research project is available to PhD students, Masters by Research, Honours students, Master of Biomedical Science to join as part of their thesis.
Please contact the Research Group Leader to discuss your options.
School Research Themes
For further information about this research, please contact the research group leader.
Department / Centre
Royal Women’s Hospital
MDHS Research library
Explore by researcher, school, project or topic.